# OnCo record paper-nct03706690-j-hematol-oncol-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct03706690-j-hematol-oncol-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct03706690-j-hematol-oncol-2025" ;
  schema:name "PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy"@en ;
  schema:description "Published report from the PACIFIC-5 trial registered as NCT03706690, in Journal of hematology & oncology (2025), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct03706690-j-hematol-oncol-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1186/s13045-025-01768-1>, <https://pubmed.ncbi.nlm.nih.gov/41354932/>, <https://europepmc.org/article/MED/41354932>, <https://clinicaltrials.gov/study/NCT03706690> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1186/s13045-025-01768-1> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Wu YL, Wu L, Bi N, et al." ;
  onco:trials <https://onco.cc/trials/nct03706690/> ;
  onco:journals <https://onco.cc/journals/journal-of-hematology-and-oncology/> .